Connected Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, By Product Type (Connected Sensors v/s Integrated Connected Devices) By Technology (Bluetooth, Near Field Communication, Others) By Application (Asthma & COPD, Diabetes, Others) By End User (Healthcare Providers v/s Homecare) By Region, and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationConnected Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, By Product Type (Connected Sensors v/s Integrated Connected Devices) By Technology (Bluetooth, Near Field Communication, Others) By Application (Asthma & COPD, Diabetes, Others) By End User (Healthcare Providers v/s Homecare) By Region, and Competition
Global connected drug delivery devices market is expected to grow at an impressive CAGR in the forecast years. Some of the key factors that are favorably affecting the sales of connected drug delivery devices around the world include increasing IoT (Internet of Things) penetration in the medical industry, advancements in drug delivery nanotechnology, among others. Additionally, growing popularity of remoted patient monitoring especially after the sudden breakdown and spread of pandemic COVID-19 is expected to open new prospects for the growth of global connected drug delivery devices market. COVID-19 increased the awareness of connected drug delivery devices and established the importance of remote monitoring for medication adherence. A lot of patients & providers started adopting connected drug delivery devices.
However, lack of awareness related to connected drug delivery devices especially in the emerging countries can slow down the market growth during the forecast period. Also, concerns related to patient data safety can slow down the market growth.
Advanced Features of Connected Drug Delivery Devices
According to International Diabetes Federation, the number of people suffering from diabetes is expected to reach 643 million by 2030.
Rising Mergers and Acquisitions along with R&D Activities
For instance, in May 2021, Glooko Inc., DexCom Inc., Roche, and myDiabby Healthcare joined up with Eli Lilly and Company to expand connected solutions for diabetics in markets outside of the United States.
Market Segmentation
Global connected drug delivery devices market is segmented by product type, technology, application, end-user, and regional distribution. Based on product type the market is further fragmented into connected sensors and integrated connected devices. based on technology the market is divided into Bluetooth, Near Field Communications, and others. Based on application the market is categorized into Asthma & COPD, Diabetes, and others. Based on end-use the market is divided into Healthcare Providers and Home Care.
Market Players
Abbott Laboratories, Inc., Reciprocal Labs Corporation (Propeller Health), F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Biocorp Production SA, Merck KGaA, Adherium Ltd, West Pharmaceutical Services, Inc., Aterica Digital Health, Molex LLC (Phillips Medisize), Cohero Health, Inc., Elcam Medical ACS. Ltd, Becton, Dickinson, and Company, Ypsomed Holding AG, Unilife Corporation, among others.
Recent Developments
Aptar Pharma in February 2022 launched HeroTracker Sense, a metered-dose inhaler (MDI) add-on which transforms a standard inhaler into a smart connected drug delivery device.
In June 2021, Adherium Limited made an announcement that they have submitted 510(k) application to the U.S. FDA for getting market clearance for their first generation Hailie sensor. This sensor is equipped with physiological measures to monitor asthma and COPD medication use.
Mallya, a smart cap for pen injectors which automatically captures data (such as the injection dose, date, and time) and transmits it in real-time via Bluetooth to companion software was launched in November 2020 by Biocorp Production SA.
| Attribute | Details |
| Base Year | 2022 |
| Historical Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Product Type · Technology · Application · End User |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States, Mexico, Canada, China, India, Japan, Australia; South Korea, Germany, France, United Kingdom, Italy, Spain, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia. |
| Key companies profiled | Abbott Laboratories, Inc., Reciprocal Labs Corporation (Propeller Health), F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Biocorp Production SA, Merck KGaA, Adherium Ltd, West Pharmaceutical Services, Inc., Aterica Digital Health, Molex LLC (Phillips Medisize), Cohero Health, Inc., Elcam Medical ACS. Ltd, Becton, Dickinson, and Company, Ypsomed Holding AG, Unilife Corporation. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy